Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population
2 other identifiers
interventional
30
1 country
1
Brief Summary
The Cancer Health Empowerment for Living without Pain (Ca-HELP) is an evidence-based communication tool that empowers and engages patients to communicate effectively with their physicians about pain. The Ca-HELP intervention is rooted in social-cognitive theory which posits that behavior change and maintenance depends largely on individuals' ability and self-efficacy to execute a specific behavior. Ca-HELP coaches patients to ask questions, make requests, and signal distress to their physicians in order to achieve improved pain control. Previous research indicates significant improvement among cancer patients in their self-efficacy to communicate about their pain to their oncologists and reductions in pain misconceptions and pain-related impairment. Although a promising tool among geriatric cancer patients, Ca-HELP is not currently designed for optimal dissemination in rural settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pain
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2020
CompletedFirst Posted
Study publicly available on registry
February 10, 2020
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2022
CompletedResults Posted
Study results publicly available
March 13, 2023
CompletedMarch 22, 2023
March 1, 2023
1 year
February 6, 2020
February 13, 2023
March 20, 2023
Conditions
Outcome Measures
Primary Outcomes (9)
Feasibility (Aim 2), as Measured by Number of Subjects Accrued to the Study
Number of subjects accrued
Two weeks post-intervention
Feasibility (Aim 2), as Measured by Number of Subjects to Complete the Intervention
Number of subjects to complete intervention
Two weeks post-intervention
Acceptability (Aim 2), as Measured by Qualitative Feedback
Semi-structured interview assessing perceived satisfaction, helpfulness, usability, and readability. This interview will be coded qualitatively for themes that assess these components for assessment of overall acceptability. Qualitative data was analyzed as number of subjects endorsing specific themes. Themes around usability and readability did not emerge from the semi-structured interviews, thus no data on usability or readability were available to analyze.
Two weeks post-intervention
Acceptability (Aim 2), as Measured by Helpfulness
Likert scale item assessing perceived helpfulness. Likert scale from 1 (not at all helpful) to 5 (very helpful), with 5 indicating higher levels of acceptability.
Two weeks post-intervention
Acceptability (Aim 2), as Measured by Satisfaction
Likert scale item assessing perceived satisfaction. Likert scale from 1 (not at all satisfied) to 5 (very satisfied), with 5 indicating higher levels of acceptability.
Two weeks post-intervention
Acceptability (Aim 2), as Measured by Usability
Likert scale item assessing perceived usability by assessing how difficult the intervention content was to understand. Likert scale from 1 (not at all) to 5 (very much). The item was reverse scored so that 5 indicates higher levels of acceptability.
Two weeks post-intervention
Acceptability (Aim 2), as Measured by Readability
Yes/no items assessing perceived readability (wording was too complicated, ideas were too complicated, there was too much information, there was not enough information). Individual items will be summed to create a total readability score. Scores can range from 0 (no issues/ good readability) to 4 (poor readability). \*Note these questions were only answered among participants who indicated that the intervention content was difficult to understand (eg, poor usability) by scoring \>1 on the 1 to 5 Likert-scale of usability.
Two weeks post-intervention
Change in Pain Self-management (Aim 3)
Two items from the pain management subscale of the Chronic Pain Self-Efficacy scale. Items rated on a 5-point Likert scale (1 = not at all certain and 5 = extremely certain). Scores range from 2 (low self-management) to 10 (high self-management).
Baseline, two weeks post-intervention
Change in Pain Misconceptions (Aim 3)
Assessed using the 11 items based on the short version of the Barriers Questionnaire. Items are rated on a five-point Likert scale (1=disagree very much, 5=agree very much). Scores range from 1 (low misconception) to 5 (high misconception) as an average across all 11 items.
Baseline, two weeks post-intervention
Secondary Outcomes (4)
Treatment Fidelity as Measured by Number of Subjects for Which the Intervention Was Delivered With Fidelity
Two weeks post-intervention
Change in Self-efficacy for Communicating With Physicians About Pain Severity
Baseline, two weeks post-intervention
Change in Pain-related Impairment
Baseline, two weeks post-intervention
Change in Pain Severity
Baseline, two weeks post-intervention
Study Arms (1)
Ca-HELP
EXPERIMENTALThis intervention arm will consist of six components: (1) Assessment of current knowledge, attitudes, and preferences; (2) clarification and correction of misconceptions about cancer pain control; (3) teaching of relevant concepts (education about cancer pain control); (4) planning (identifying goals of care, creating achievable goals of care, and creating strategies to communicate goals of care to providers and family members); (5) rehearsal of communication strategies using role play exercises; and (6) portrayal of learned skills (patient applies skills in visit with healthcare provider).
Interventions
Intervention group: This intervention will be informed by social-cognitive theory10-13 and modeled after the tailored education and coaching intervention (TEC) used for Ca-HELP previously and consists of six components: (1) Assessment of current knowledge, attitudes, and preferences; (2) clarification and correction of misconceptions about cancer pain control; (3) teaching of relevant concepts (education about cancer pain control); (4) planning (identifying goals of care, creating achievable goals of care, and creating strategies to communicate goals of care to providers and family members); (5) rehearsal of communication strategies using role play exercises; and (6) portrayal of learned skills (patient applies skills in visit with healthcare provider).
Eligibility Criteria
You may qualify if:
- years of age or older
- Diagnosed with cancer
- English speaking
- Reside in non-institutional, rural settings
- Receive care at community-based clinic in rural area
- Ability to provide informed consent
- Have identified an informal caregiver.
You may not qualify if:
- Severe cognitively impairment (Short Portable Mental Status Questionnaire scores of \<6);
- Receiving hospice at time of enrollment.
- Caregiver eligibility criteria include the following
- The person (family member or friend) whom the patient indicates provides most of their informal care
- Able to provide informed consent.
- Provider eligibility criteria:
- Currently works with geriatric cancer patients OR in a healthcare system serving this patient population. Providers will include social workers, nurses, oncologists, and healthcare administrators.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- Maury Regional Medical Centercollaborator
- Brown Universitycollaborator
- National Institute on Aging (NIA)collaborator
- Fred Hutchinson Cancer Centercollaborator
Study Sites (1)
Maury Regional Medical Center
Columbia, Tennessee, 38401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Megan Shen
- Organization
- Fred Hutchinson Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Cary Reid, MD, PhD
Weill Medical College of Cornell University
- PRINCIPAL INVESTIGATOR
Megan Shen, PhD
Fred Hutchinson Cancer Center
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No masking due to this being a single arm study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2020
First Posted
February 10, 2020
Study Start
May 1, 2021
Primary Completion
May 5, 2022
Study Completion
May 5, 2022
Last Updated
March 22, 2023
Results First Posted
March 13, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share